Back
Corcept Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
87
CORT
Corcept Therapeutics
Last Price:
59.57
Seasonality Move:
3.97%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.72 | Buy |
| 20-day SMA: | 49.28 | Buy |
| 50-day SMA: | 44.07 | Buy |
| 200-day SMA: | 32 | Buy |
| 8-day EMA: | 53.06 | Buy |
| 20-day EMA: | 49.83 | Buy |
| 50-day EMA: | 45.17 | Buy |
| 200-day EMA: | 35.31 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.95 | Buy |
| Relative Strength Index (14 RSI): | 80.63 | Buy |
| Chaikin Money Flow: | 759215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.11 - 51.89) | Buy |
| Bollinger Bands (100): | (31.7 - 45.68) | Buy |
Corcept Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 59.60 while CORT 8-day simple moving average is 51.72, which is a Buy signal.
- The stock price of CORT is 59.60 while Corcept Therapeutics 20-day SMA is 49.28, which makes it a Buy.
- Corcept Therapeutics 50-day simple moving average is 44.07 while CORT share price is 59.60, making it a Buy technically.
- CORT stock price is 59.60 and Corcept Therapeutics 200-day simple moving average is 32.00, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
87
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a Buy
The current Corcept Therapeutics [CORT] share price is $59.60. The Score for CORT is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
6.24B
Price in USD:
59.60
Share Volume:
1.73M
Corcept Therapeutics 52-Week Range
52-Week High:
61.66
52-Week Low:
20.84
Buy
87
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?
The Corcept Therapeutics stock price is 59.60 USD today. -
Will CORT stock go up or go down?
Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Corcept Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 59.60 while CORT 8-day exponential moving average is 53.06, which is a Buy signal.
- The stock price of CORT is 59.60 while Corcept Therapeutics 20-day EMA is 49.83, which makes it a Buy.
- Corcept Therapeutics 50-day exponential moving average is 45.17 while CORT share price is 59.60, making it a Buy technically.
- CORT stock price is 59.60 and Corcept Therapeutics 200-day simple moving average is 35.31, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
- CORT Moving Average Covergence Divergence (MACD) indicator is 2.95, suggesting Corcept Therapeutics is a Buy
- Corcept Therapeutics Relative Strength Index (RSI) is 80.63, which suggest Corcept Therapeutics is overbought
- The Bollinger Bands (25) for Corcept Therapeutics is (45.11 - 51.89), which suggest Corcept Therapeutics is a Buy
- The Bollinger Bands (100) for Corcept Therapeutics is (31.7 - 45.68), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.